Gastrointestinal Stromal Tumors, Somatic Mutations and Candidate Genetic Risk Variants

被引:24
|
作者
O'Brien, Katie M. [1 ]
Orlow, Irene [2 ]
Antonescu, Cristina R. [3 ]
Ballman, Karla [4 ]
McCall, Linda [5 ]
DeMatteo, Ronald [6 ]
Engel, Lawrence S. [1 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[4] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[5] Amer Coll Surg, Oncol Grp, Durham, NC USA
[6] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
来源
PLOS ONE | 2013年 / 8卷 / 04期
关键词
S-TRANSFERASE M1; CYP1B1 LEU432VAL POLYMORPHISM; COLORECTAL-CANCER RISK; SOFT-TISSUE SARCOMA; SINGLE NUCLEOTIDE POLYMORPHISMS; GERMLINE MUTATION; BLADDER-CANCER; DNA-REPAIR; C-KIT; ASSOCIATION;
D O I
10.1371/journal.pone.0062119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Gastrointestinal stromal tumors (GISTs) are rare but treatable soft tissue sarcomas. Nearly all GISTs have somatic mutations in either the KIT or PDGFRA gene, but there are no known inherited genetic risk factors. We assessed the relationship between KIT/PDGFRA mutations and select deletions or single nucleotide polymorphisms (SNPs) in 279 participants from a clinical trial of adjuvant imatinib mesylate. Given previous evidence that certain susceptibility loci and carcinogens are associated with characteristic mutations, or "signatures'' in other cancers, we hypothesized that the characteristic somatic mutations in the KIT and PDGFRA genes in GIST tumors may similarly be mutational signatures that are causally linked to specific mutagens or susceptibility loci. As previous epidemiologic studies suggest environmental risk factors such as dioxin and radiation exposure may be linked to sarcomas, we chose 208 variants in 39 candidate genes related to DNA repair and dioxin metabolism or response. We calculated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between each variant and 7 categories of tumor mutation using logistic regression. We also evaluated gene-level effects using the sequence kernel association test (SKAT). Although none of the association p-values were statistically significant after adjustment for multiple comparisons, SNPs in CYP1B1 were strongly associated with KIT exon 11 codon 557-8 deletions (OR = 1.9, 95% CI: 1.3-2.9 for rs2855658 and OR = 1.8, 95% CI: 1.2-2.7 for rs1056836) and wild type GISTs (OR = 2.7, 95% CI: 1.5-4.8 for rs1800440 and OR = 0.5, 95% CI: 0.3-0.9 for rs1056836). CYP1B1 was also associated with these mutations categories in the SKAT analysis (p = 0.002 and p = 0.003, respectively). Other potential risk variants included GSTM1, RAD23B and ERCC2. This preliminary analysis of inherited genetic risk factors for GIST offers some clues about the disease's genetic origins and provides a starting point for future candidate gene or gene-environment research.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Gastrointestinal stromal tumors: a case-only analysis of single nucleotide polymorphisms and somatic mutations
    O'Brien, Katie M.
    Orlow, Irene
    Antonescu, Cristina R.
    Ballman, Karla
    McCall, Linda
    DeMatteo, Ronald
    Engel, Lawrence S.
    CLINICAL SARCOMA RESEARCH, 2013, 3
  • [2] Gastrointestinal stromal tumors
    Beham, Alexander W.
    Schaefer, Inga-Marie
    Schueler, Philipp
    Cameron, Silke
    Ghadimi, B. Michael
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (06) : 689 - 700
  • [3] Molecular Analysis of the KIT Gene in Gastrointestinal Stromal Tumors With Novel Mutations
    Calibasi, Gizem
    Baskin, Yasemin
    Alyuruk, Hakan
    Cavas, Levent
    Oztop, Ilhan
    Sagol, Ozgul
    Atila, Koray
    Ellidokuz, Hulya
    Yilmaz, Ugur
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 37 - 45
  • [4] Immunohistochemical and molecular genetic analyses of multiple sporadic gastrointestinal stromal tumors
    Hiraki, Masatsugu
    Kitajima, Yoshihiko
    Ohtsuka, Takao
    Kai, Keita
    Miyake, Shuusuke
    Koga, Yasuo
    Mori, Daisuke
    Noshiro, Hirokazu
    Tokunaga, Osamu
    Miyazaki, Kohji
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (09) : 364 - 368
  • [5] Immunohistochemical and molecular genetic analyses of multiple sporadic gastrointestinal stromal tumors
    Masatsugu Hiraki
    Yoshihiko Kitajima
    Takao Ohtsuka
    Keita Kai
    Shuusuke Miyake
    Yasuo Koga
    Daisuke Mori
    Hirokazu Noshiro
    Osamu Tokunaga
    Kohji Miyazaki
    World Journal of Gastrointestinal Oncology, 2010, (09) : 364 - 368
  • [6] Syndromic gastrointestinal stromal tumors
    Ricci, Riccardo
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2016, 14
  • [7] Prognostic Relevance of KIT and PDGFRA Mutations in Gastrointestinal Stromal Tumors
    Braggio, Esteban
    Braggio, Danielle De Almeida
    Small, Isabele Avila
    Lopes, Lisandro F.
    Valadao, Marcus
    Gouveia, Maria Emmerick
    Moreira, Aline Dos Santos
    Linhares, Eduardo
    Romano, Sergio
    Bacchi, Carlos E.
    Renault, Ilana Zalcberg
    Guimaraes, Denise Peixoto
    Ferreira, Carlos Gil
    ANTICANCER RESEARCH, 2010, 30 (06) : 2407 - 2414
  • [8] Gastrointestinal Stromal Tumors Molecular Markers and Genetic Subtypes
    Barnett, Christine M.
    Corless, Christopher L.
    Heinrich, Michael C.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (05) : 871 - 888
  • [9] KIT and PDGFRA mutations and PDGFRA immunostaining in gastrointestinal stromal tumors
    Barreca, Antonella
    Fornari, Alessandro
    Bonello, Lisa
    Tondat, Fabrizio
    Chiusa, Luigi
    Lista, Patrizia
    Pich, Achille
    MOLECULAR MEDICINE REPORTS, 2011, 4 (01) : 3 - 8
  • [10] Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
    Caenepeel, Sean
    Renshaw-Gegg, Lisa
    Baher, Angelo
    Bush, Tammy L.
    Baron, Will
    Juan, Todd
    Manoukian, Raffi
    Tasker, Andrew S.
    Polverino, Anthony
    Hughes, Paul E.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29